122 related articles for article (PubMed ID: 12008122)
1. Rapid quantification of constituents in St. John's wort extracts by NIR spectroscopy.
Rager I; Roos G; Schmidt PC; Kovar KA
J Pharm Biomed Anal; 2002 May; 28(3-4):439-46. PubMed ID: 12008122
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression.
Obach RS
J Pharmacol Exp Ther; 2000 Jul; 294(1):88-95. PubMed ID: 10871299
[TBL] [Abstract][Full Text] [Related]
3. Measurement of hyperforin a constituent of St. John's wort in plasma by high-performance liquid chromatography.
Chi JD; Franklin M
J Chromatogr B Biomed Sci Appl; 1999 Dec; 735(2):285-8. PubMed ID: 10670742
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of the major constituents of St John's wort with HPLC-ESI-MS.
Chandrasekera DH; Welham KJ; Ashton D; Middleton R; Heinrich M
J Pharm Pharmacol; 2005 Dec; 57(12):1645-52. PubMed ID: 16354409
[TBL] [Abstract][Full Text] [Related]
5. Optimization of Light Intensity, Temperature, and Nutrients to Enhance the Bioactive Content of Hyperforin and Rutin in St. John's Wort.
Kuo CH; Chou YC; Liao KC; Shieh CJ; Deng TS
Molecules; 2020 Sep; 25(18):. PubMed ID: 32948004
[TBL] [Abstract][Full Text] [Related]
6. Comparison of German St. John's wort products according to hyperforin and total hypericin content.
Wurglics M; Westerhoff K; Kaunzinger A; Wilke A; Baumeister A; Dressman J; Schubert-Zsilavecz M
J Am Pharm Assoc (Wash); 2001; 41(4):560-6. PubMed ID: 11486982
[TBL] [Abstract][Full Text] [Related]
7. Effect of eluent pH on the HPLC-UV analysis of hyperforin from St. John's Wort (Hypericum perforatum L.).
Fourneron JD; Naït-Si Y
Phytochem Anal; 2006; 17(2):71-7. PubMed ID: 16634282
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of St. John's wort from different Italian regions.
Pietta P; Gardana C; Pietta A
Farmaco; 2001; 56(5-7):491-6. PubMed ID: 11482784
[TBL] [Abstract][Full Text] [Related]
9. In vitro binding studies with two hypericum perforatum extracts--hyperforin, hypericin and biapigenin--on 5-HT6, 5-HT7, GABA(A)/benzodiazepine, sigma, NPY-Y1/Y2 receptors and dopamine transporters.
Gobbi M; Moia M; Pirona L; Morizzoni P; Mennini T
Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S45-8. PubMed ID: 11518075
[TBL] [Abstract][Full Text] [Related]
10. Liquid chromatography-tandem mass spectrometry of I3,II8-biapigenin, the major biflavone in Hypericum perforatum extracts.
Colovic M; Caccia S
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Feb; 863(1):74-9. PubMed ID: 18243074
[TBL] [Abstract][Full Text] [Related]
11. Determining hyperforin and hypericin content in eight brands of St. John's wort.
de los Reyes GC; Koda RT
Am J Health Syst Pharm; 2002 Mar; 59(6):545-7. PubMed ID: 11908248
[No Abstract] [Full Text] [Related]
12. Quantitative analysis of the active components and the by-products of eight dry extracts of Hypericum perforatum L. (St John's Wort).
von Eggelkraut-Gottanka SG; Abu Abed S; Müller W; Schmidt PC
Phytochem Anal; 2002; 13(3):170-6. PubMed ID: 12099108
[TBL] [Abstract][Full Text] [Related]
13. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
Tian R; Koyabu N; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive phytochemical characterization of St. John's wort (
Heinrich M; Daniels R; Stintzing FC; Kammerer DR
Pharmazie; 2017 Mar; 72(3):131-138. PubMed ID: 29442047
[TBL] [Abstract][Full Text] [Related]
15. Enrichment of hyperforin from St. John's wort (Hypericum perforatum) by pilot-scale supercritical carbon dioxide extraction.
Römpp H; Seger C; Kaiser CS; Haslinger E; Schmidt PC
Eur J Pharm Sci; 2004 Mar; 21(4):443-51. PubMed ID: 14998574
[TBL] [Abstract][Full Text] [Related]
16. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.
Chrubasik-Hausmann S; Vlachojannis J; McLachlan AJ
J Pharm Pharmacol; 2019 Jan; 71(1):129-138. PubMed ID: 29411879
[TBL] [Abstract][Full Text] [Related]
17. Quantitative changes of dianthrones, hyperforin and flavonoids content in the flower ontogenesis of Hypericum perforatum.
Tekel'ová D; Repcák M; Zemková E; Tóth J
Planta Med; 2000 Dec; 66(8):778-80. PubMed ID: 11199145
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous determination of the predominant hyperforins and hypericins in St. John's Wort (Hypericum perforatum L.) by liquid chromatography.
Gray DE; Rottinghaus GE; Garrett HE; Pallardy SG; Gray DE; Rottinghaus GE; Garrett HE; Pallardy SG
J AOAC Int; 2000; 83(4):944-9. PubMed ID: 10995119
[TBL] [Abstract][Full Text] [Related]
19. Development of a simple, rapid and reproducible HPLC assay for the simultaneous determination of hypericins and stabilized hyperforin in commercial St. John's wort preparations.
de los Reyes GC; Koda RT
J Pharm Biomed Anal; 2001 Dec; 26(5-6):959-65. PubMed ID: 11600308
[TBL] [Abstract][Full Text] [Related]
20. Fast high-performance liquid chromatographic analysis of naphthodianthrones and phloroglucinols from Hypericum perforatum extracts.
Tolonen A; Hohtola A; Jalonen J
Phytochem Anal; 2003; 14(5):306-9. PubMed ID: 14516003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
